Guest guest Posted April 16, 2001 Report Share Posted April 16, 2001 From: " Ilena Rose " <ilena@...> Sent: Monday, April 09, 2001 12:38 PM Subject: Name Game Shenanigans of the Pharmaceutical Cartel Women's pill is really Prozac > > By LEWIS KRAUSKOPF > Staff Writer > > About nine months ago, Eli Lilly & Co. won > federal approval to market its drug Sarafem for > a severe form of premenstrual syndrome. > > Available as a pink-and-lavender capsule, > Sarafem, according to Eli Lilly's Web site for the > drug, " is the first and only FDA-approved > treatment for both the mood and physical > symptoms of Premenstrual Dysphoric Disorder > (PMDD). " > > Sarafem, however, isn't a new chemical > discovery. It is a repackaged, renamed version > of the Indianapolis company's globally popular > antidepressant, Prozac -- they are chemically the > same, though Prozac capsules are colored green > and cream. > > It is common for drug companies to seek Food > and Drug Administration approval to market a > drug for more than one therapeutic use, as Lilly > did. But an FDA representative could recall only > a few situations in which the drug was then > renamed. > > On Tuesday, Lilly's marketing campaign for > Sarafem came under fire from a New Jersey > healthcare group, which said " it has grave > concerns about the marketing of Prozac under a > new name. " > > " The big issue is people ought to know what > they're taking, " said Dave Knowlton, chairman > of the quality and data committee of the Health > Care Payers Coalition of New Jersey. " Why isn't > the name of this drug Prozac? That should be > the name of it. " > > Eli Lilly said Tuesday that it used a different > name because the repackaged drug is treating a > different condition. The company said it states > in its patient education and advertising that > Sarafem contains the same active ingredient as > Prozac. > > " PMDD and depression are two distinct > disorders, " said , a spokeswoman > for Eli Lilly. " Prozac is probably one of the > most well-known trademarks in the industry > closely associated with depression. . . . Since > PMDD is not depression, we felt an additional > trademark would help women differentiate > PMDD from depression. " > > The active ingredient for Prozac and Sarafem is > fluoxetine hydrochloride. Under Prozac, > fluoxetine is approved by the FDA for treating > people with depression, bulimia, and > obsessive-compulsive disorder. > > PMDD's symptoms include severe mood > swings, irritability, and physical symptoms such > as bloating. It affects 3 percent to 5 percent of > menstruating women, according to Lilly. > > By marketing the drug under the name Sarafem, > the company said it is easier to educate women > about PMDD. > > But the New Jersey coalition, which is a > non-profit group of businesses and unions that > offers state residents health-quality information > and access to health-care providers, said that the > company's direct-to-consumer advertising > campaign for Sarafem is making the disorder > seem more widespread than it is. > > " They are inappropriately implying that this > drug is for a much more mainstream condition > than what it's indicated, " Knowlton said. > " They're not going on prime-time ads to market > this to 3 percent of the population. " > > Bob Kirby, an analyst with , > predicts that Sarafem sales will peak at about > $100 million a year, a tiny amount compared to > the $2.6 billion brought in last year by Prozac, > which stands to lose its patent protection this > year. > > Kirby suggested that Lilly may be using the > name Sarafem because Prozac could carry a > stigma for some people. > > " There might be a reluctance to take a drug > classified as an antidepressant when you want to > take it for " PMDD, Kirby said. > > Eli Lilly isn't the only company marketing a > drug under different names. GlaxoKline > PLC has been selling its antidepressant > Wellbutrin as a quit-smoking drug under the > name Zyban since 1997. Both products have the > same active ingredient, bupropion. > > A patient who is depressed and wants to quit > smoking could unintentionally take an overdose > of bupropion by using both Wellbutrin and > Zyban, the Institute for Safe Medication > Practices warns. To prevent that, the group > advises patients to provide a list of all their > medications to all healthcare professional who > treat them. > > Staff Writer Krauskopf's e-mail address is > krauskopf@... > > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.